section name header

Pronunciation

SOE-dee-um bye-KAR-boe-nate audio

Indications

REMS

Unlabeled Use:

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Following oral administration, excess bicarbonate is absorbed and results in metabolic alkalosis and alkaline urine.

Distribution: Widely distributed into extracellular fluid.

Metabolism/Excretion: Sodium and bicarbonate are excreted by the kidneys.

Half-life: Unknown.

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: edema.

GI: PO: flatulence, gastric distention.

F and E: metabolic alkalosis, hypernatremia, hypocalcemia, hypokalemia, sodium and water retention.

Local: irritation at IV site.

Neuro: tetany, cerebral hemorrhage (with rapid injection in infants).

Interactions

Drug-Drug:

Route/Dosage

see Calculator

Contains 12 mEq of sodium/g

Alkalinization of Urine

Antacid

Systemic Alkalinization/Cardiac Arrest

Renal Tubular Acidosis

Implementation

US Brand Names

Baking Soda, Bell-Ans, Citrocarbonate, Neut, Soda Mint

Classifications

Therapeutic Classification: antiulcer agents

Pharmacologic Classification: alkalinizing agents

Availability

(Generic available)

Time/Action Profile

(PO = antacid effect; IV = alkalinization)

ROUTEONSETPEAKDURATION
POimmediate30 min1–3 hr
IVimmediaterapidunknown

Assessment

Lab Test Considerations:

Pot. Nursing Diagnoses

Patient/Family Teaching

Evaluation/Desired Outcomes

Code

NDC Code*